Meeting of the National Advisory Council for Healthcare Research and Quality, 59625 [2019-24081]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
the aggregation and analysis of patient
safety events.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from Symbria SAFE, a component entity
of Symbria Inc., to voluntarily
relinquish its status as a PSO.
Accordingly, Symbria SAFE, P0146, was
delisted effective at 12:00 Midnight ET
(2400) on October 31, 2019.
Symbria SAFE has patient safety work
product (PSWP) in its possession. The
PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019–24152 Filed 11–4–19; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
16:34 Nov 04, 2019
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
DATES: The meeting will be held on
Thursday, November 21, 2019, from
8:30 a.m. to 12:00 p.m.
ADDRESSES: The meeting will be held at
AHRQ, 5600 Fishers Lane, Rockville,
Maryland, 20857.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Thursday, November 7, 2019. The
agenda, roster, and minutes will be
available from Ms. Heather Phelps,
Committee Management Officer, Agency
for Healthcare Research and Quality,
5600 Fishers Lane, Rockville, Maryland
20857. Ms. Phelps’ phone number is
(301) 427–1128.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
59625
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Thursday, November 21, 2019, the
Council meeting will convene at 8:30
a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting is
open to the public and will be available
via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s budget, programs and
initiatives. The agenda will also include
a discussion about the challenges and
opportunities to leverage AHRQ’s CDS
Connect to improve care and a
conversation about the gaps and
opportunities for improving care, with a
focus on social determinants of health.
The meeting will adjourn at 12:00 p.m.
The final agenda will be available on the
AHRQ website at www.AHRQ.gov no
later than Thursday, November 14,
2019.
Dated: October 30, 2019.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019–24081 Filed 11–4–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Reporting of Pregnancy Success Rates
From Assisted Reproductive
Technology (ART) Programs;
Clarifications and Corrections
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces
clarifications for and correction to
certain data collection fields,
terminology, and definitions used for
reporting of pregnancy success rates
from assisted reproductive technology
(ART) programs. This reporting is
required by the Fertility Clinic Success
Rate and Certification Act of 1992
(FCSRCA).
SUMMARY:
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Page 59625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24081]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the National Advisory
Council for Healthcare Research and Quality.
DATES: The meeting will be held on Thursday, November 21, 2019, from
8:30 a.m. to 12:00 p.m.
ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane,
Rockville, Maryland, 20857.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at
(301) 427-1998 or [email protected].
If sign language interpretation or other reasonable accommodation
for a disability is needed, please contact the Food and Drug
Administration (FDA) Office of Equal Employment Opportunity and
Diversity Management on (301) 827-4840, no later than Thursday,
November 7, 2019. The agenda, roster, and minutes will be available
from Ms. Heather Phelps, Committee Management Officer, Agency for
Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland
20857. Ms. Phelps' phone number is (301) 427-1128.
SUPPLEMENTARY INFORMATION:
I. Purpose
In accordance with section 10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App., this notice announces a meeting of the National
Advisory Council for Healthcare Research and Quality (the Council). The
Council is authorized by Section 941 of the Public Health Service Act,
42 U.S.C. 299c. In accordance with its statutory mandate, the Council
is to advise the Secretary of the Department of Health and Human
Services and the Director of AHRQ on matters related to AHRQ's conduct
of its mission including providing guidance on (A) priorities for
health care research, (B) the field of health care research including
training needs and information dissemination on health care quality and
(C) the role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Thursday, November 21, 2019, the Council meeting will convene at
8:30 a.m., with the call to order by the Council Chair and approval of
previous Council summary notes. The meeting is open to the public and
will be available via webcast at www.webconferences.com/ahrq. The
meeting will begin with an update on AHRQ's budget, programs and
initiatives. The agenda will also include a discussion about the
challenges and opportunities to leverage AHRQ's CDS Connect to improve
care and a conversation about the gaps and opportunities for improving
care, with a focus on social determinants of health. The meeting will
adjourn at 12:00 p.m. The final agenda will be available on the AHRQ
website at www.AHRQ.gov no later than Thursday, November 14, 2019.
Dated: October 30, 2019.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019-24081 Filed 11-4-19; 8:45 am]
BILLING CODE 4160-90-P
